These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 29143875)

  • 21. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study.
    Rutegård MK; Båtsman M; Axelsson J; Brynolfsson P; Brännström F; Rutegård J; Ljuslinder I; Blomqvist L; Palmqvist R; Rutegård M; Riklund K
    Cancer Imaging; 2019 Jul; 19(1):52. PubMed ID: 31337428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of simultaneous whole-body
    Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Recurrence-Free Survival After Upfront Surgery in Resectable Pancreatic Ductal Adenocarcinoma: A Preoperative Risk Score Based on CA 19-9, CT, and
    Jeong B; Oh M; Lee SS; Kim N; Kim JS; Lee W; Kim SC; Kim HJ; Kim JH; Byun JH
    Korean J Radiol; 2024 Jul; 25(7):644-655. PubMed ID: 38942458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
    Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
    Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Santhosh S; Mittal BR; Bhasin DK; Rana SS; Gupta R; Das A; Nada R
    Ann Nucl Med; 2017 Oct; 31(8):575-581. PubMed ID: 28689356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/MRI for evaluation of patients with pancreatic cancer.
    Duncan ZN; Summerlin D; West JT; Packard AT; Morgan DE; Galgano SJ
    Abdom Radiol (NY); 2023 Dec; 48(12):3601-3609. PubMed ID: 37191756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
    Montemagno C; Cassim S; De Leiris N; Durivault J; Faraggi M; Pagès G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/CT of cancer patients: part 1, pancreatic neoplasms.
    Dibble EH; Karantanis D; Mercier G; Peller PJ; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2012 Nov; 199(5):952-67. PubMed ID: 23096166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
    J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from
    Gao J; Bai Y; Miao F; Huang X; Schwaiger M; Rominger A; Li B; Zhu H; Lin X; Shi K
    Clin Radiol; 2023 Oct; 78(10):746-754. PubMed ID: 37487840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
    Rose DM; Delbeke D; Beauchamp RD; Chapman WC; Sandler MP; Sharp KW; Richards WO; Wright JK; Frexes ME; Pinson CW; Leach SD
    Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy.
    Ikenaga N; Nakata K; Hayashi M; Nakamura S; Abe T; Ideno N; Murakami M; Fujimori N; Fujita N; Isoda T; Baba S; Ishigami K; Oda Y; Nakamura M
    J Gastrointest Surg; 2023 Feb; 27(2):337-346. PubMed ID: 36652179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancer.
    Liu X; Ren Y; Wang J; Yang X; Lu L
    Contrast Media Mol Imaging; 2022; 2022():1479416. PubMed ID: 36017022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early recurrence detected by 18F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma.
    Wang L; Dong P; Wang W; Li M; Hu W; Liu X; Tian B
    Medicine (Baltimore); 2020 Mar; 99(11):e19504. PubMed ID: 32176094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular radionuclide imaging of pancreatic neoplasms.
    Panda A; Garg I; Johnson GB; Truty MJ; Halfdanarson TR; Goenka AH
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):559-570. PubMed ID: 31169124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.